|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"qin s"
Showing items 26-35 of 74 (8 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 > >>
View [10|25|50] records per page
| 國立成功大學 |
2022 |
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
|
Chan, S.L.;Schuler, M.;Kang, Y.-K.;Yen, C.-J.;Edeline, J.;Choo, S.P.;Lin, C.-C.;Okusaka, T.;Weiss, K.-H.;Macarulla, T.;Cattan, S.;Blanc, J.-F.;Lee, K.-H.;Maur, Maur M.;Pant, S.;Kudo, M.;Assenat, E.;Zhu, A.X.;Yau, T.;Lim, H.Y.;Bruix, J.;Geier, A.;Guill�n-Ponce, C.;Fasolo, A.;Finn, R.S.;Fan, J.;Vogel, A.;Qin, S.;Riester, M.;Katsanou, V.;Chaudhari, M.;Kakizume, T.;Gu, Y.;Porta, D.G.;Myers, A.;Delord, J.-P. |
| 國立成功大學 |
2022 |
Improving polygenic prediction in ancestrally diverse populations
|
Ruan, Y.;Lin, Y.-F.;Feng, Y.-C.A.;Chen, Chen C.-Y.;Lam, M.;Guo, Z.;Ahn, Y.M.;Akiyama, K.;Arai, M.;Baek, J.H.;Chen, W.J.;Chung, Y.-C.;Feng, G.;Fujii, K.;Glatt, S.J.;Ha, K.;Hattori, K.;Higuchi, T.;Hishimoto, A.;Hong, K.S.;Horiuchi, Y.;Hwu, Hwu H.-G.;Ikeda, M.;Ishiwata, S.;Itokawa, M.;Iwata, N.;Joo, E.-J.;Kahn, R.S.;Kim, S.-W.;Kim, S.J.;Kim, S.H.;Kinoshita, M.;Kunugi, H.;Kusumawardhani, A.;Lee, J.;Lee, B.D.;Lee, H.-J.;Liu, J.;Liu, R.;Ma, X.;Myung, W.;Numata, S.;Ohmori, T.;Otsuka, I.;Ozeki, Y.;Schwab, Schwab S.G.;Shi, W.;Shimoda, K.;Sim, K.;Sora, I.;Tang, J.;Toyota, Toyota T.;Tsuang, M.;Wildenauer, D.B.;Won, H.-H.;Yoshikawa, T.;Zheng, A.;Zhu, F.;He, L.;Sawa, A.;Martin, A.R.;Qin, S.;Huang, Huang H.;Ge, T.;Initiatives, Stanley Global Asia |
| 臺大學術典藏 |
2021-10-22T07:39:40Z |
Comparative genetic architectures of schizophrenia in East Asian and European populations
|
Lam M.; Chen C.-Y.; Li Z.; Martin A.R.; Bryois J.; Ma X.; Gaspar H.; Ikeda M.; Benyamin B.; Brown B.C.; Liu R.; Zhou W.; Guan L.; Kamatani Y.; Kim S.-W.; Kubo M.; Kusumawardhani A.A.A.A.; Liu C.-M.; Ma H.; Periyasamy S.; Takahashi A.; Xu Z.; Yu H.; Zhu F.; Chen W.J.; Faraone S.; Glatt S.J.; He L.; Hyman S.E.; HAI-GWO HWU; McCarroll S.A.; Neale B.M.; Sklar P.; Wildenauer D.B.; Yu X.; Zhang D.; Mowry B.J.; Lee J.; Holmans P.; Xu S.; Sullivan P.F.; Ripke S.; O’Donovan M.C.; Daly M.J.; Qin S.; Sham P.; Iwata N.; Hong K.S.; Schwab S.G.; Yue W.; Tsuang M.; Liu J.; Ma X.; Kahn R.S.; Shi Y.; Huang H.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Indonesia Schizophrenia Consortium, Genetic REsearch on schizophreniA neTwork-China and the Netherlands (GREAT-CN) |
| 臺大學術典藏 |
2021-09-23T08:02:06Z |
Comparative genetic architectures of schizophrenia in East Asian and European populations
|
Lam M.; Chen C.-Y.; Li Z.; Martin A.R.; Bryois J.; Ma X.; Gaspar H.; Ikeda M.; Benyamin B.; Brown B.C.; Liu R.; Zhou W.; Guan L.; Kamatani Y.; Kim S.-W.; Kubo M.; Kusumawardhani A.A.A.A.; CHIH-MIN LIU; Ma H.; Periyasamy S.; Takahashi A.; Xu Z.; Yu H.; Zhu F.; Chen W.J.; Faraone S.; Glatt S.J.; He L.; Hyman S.E.; Hwu H.-G.; McCarroll S.A.; Neale B.M.; Sklar P.; Wildenauer D.B.; Yu X.; Zhang D.; Mowry B.J.; Lee J.; Holmans P.; Xu S.; Sullivan P.F.; Ripke S.; O’Donovan M.C.; Daly M.J.; Qin S.; Sham P.; Iwata N.; Hong K.S.; Schwab S.G.; Yue W.; Tsuang M.; Liu J.; Ma X.; Kahn R.S.; Shi Y.; Huang H.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Indonesia Schizophrenia Consortium, Genetic REsearch on schizophreniA neTwork-China and the Netherlands (GREAT-CN) |
| 臺大學術典藏 |
2021-09-01T01:54:24Z |
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
|
ANN-LII CHENG; Kang Y.-K.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Luo R.; Feng J.; Ye S.; Yang T.-S.; Xu J.; Sun Y.; Liang H.; Liu J.; Wang J.; Tak W.Y.; Pan H.; Burock K.; Zou J.; Voliotis D.; Guan Z. |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial
|
ANN-LII CHENG; Guan Z.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Yang T.-S.; Tak W.Y.; Pan H.; Yu S.; Xu J.; Fang F.; Zou J.; Lentini G.; Voliotis D.; Kang Y.-K. |
| 臺大學術典藏 |
2021-09-01T01:53:44Z |
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL study
|
Johnson P.J.; Qin S.; Park J.-W.; Poon R.T.P.; Raoul J.-L.; Philip P.A.; Hsu C.-H.; Hu T.-H.; Heo J.; Xu J.; Lu L.; Chao Y.; Boucher E.; Han K.-H.; Paik S.-W.; Robles-Avi?a J.; Kudo M.; Yan L.; Sobhonslidsuk A.; Komov D.; Decaens T.; Tak W.-Y.; Jeng L.-B.; Liu D.; Ezzeddine R.; Walters I.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:43Z |
Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial
|
ANN-LII CHENG; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. |
| 臺大學術典藏 |
2021-08-31T06:29:40Z |
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Bruix J.; Qin S.; Merle P.; Granito A.; Huang Y.-H.; Bodoky G.; Pracht M.; Yokosuka O.; Rosmorduc O.; Breder V.; Gerolami R.; Masi G.; Ross P.J.; Song T.; Bronowicki J.-P.; Ollivier-Hourmand I.; Kudo M.; ANN-LII CHENG; Llovet J.M.; Finn R.S.; LeBerre M.-A.; Baumhauer A.; Meinhardt G.; Han G. |
| 臺大學術典藏 |
2021-08-31T06:29:31Z |
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
|
Bouattour M.; Raymond E.; Qin S.; ANN-LII CHENG; Stammberger U.; Locatelli G.; Faivre S. |
Showing items 26-35 of 74 (8 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 > >>
View [10|25|50] records per page
|
